A Shuaib Selected Research

A Shuaib Research Topics

Disease

13	Stroke (Strokes) 01/2018 - 02/2000
10	Ischemia 03/2001 - 01/2000
9	Brain Ischemia (Cerebral Ischemia) 09/2001 - 03/2000
8	Ischemic Stroke 10/2014 - 02/2000
5	Brain Infarction 06/2001 - 03/2000
4	Brain Injuries (Brain Injury) 10/2004 - 08/2000
4	Infarction (Infarctions) 08/2001 - 03/2000
3	Transient Ischemic Attack 09/2001 - 02/2000
3	Embolic Stroke 06/2001 - 03/2000
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2001 - 03/2001
2	Atrial Fibrillation 08/2001 - 02/2001
2	Thrombosis (Thrombus) 05/2000 - 05/2000
2	Cerebral Hemorrhage 05/2000 - 03/2000
1	Sleepiness 01/2002
1	Reperfusion Injury 09/2001
1	Acute Coronary Syndrome 04/2001
1	Vascular Diseases (Vascular Disease) 06/2000
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2000
1	Unstable Angina 06/2000
1	Myocardial Infarction 06/2000
1	Stuttering (Stammering) 06/2000
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 06/2000
1	Cerebral Infarction 05/2000
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2000
1	Hyperglycemia 01/2000

Drug/Important Bio-Agent (IBA)

7	Neuroprotective AgentsIBA 10/2004 - 02/2000
3	Glutamic Acid (Glutamate)FDA Link 09/2001 - 01/2000
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 08/2001 - 05/2000
3	triphenyltetrazoliumIBA 08/2001 - 08/2000
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2000 - 02/2000
2	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2005 - 10/2004
2	Free RadicalsIBA 10/2004 - 05/2000
2	Warfarin (Coumadin)FDA LinkGeneric 08/2001 - 02/2001
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2001 - 06/2000
2	Excitatory Amino AcidsIBA 11/2000 - 01/2000
2	GABA Agonists (GABA Receptor Agonists)IBA 08/2000 - 07/2000
2	Tiagabine (Gabitril)FDA Link 08/2000 - 07/2000
2	Topiramate (Topamax)FDA LinkGeneric 05/2000 - 03/2000
2	Taurine FDA Link 02/2000 - 01/2000
1	salicylhydroxamic acid (SHAM)IBA 10/2014
1	ORALIT (ORS)IBA 12/2013
1	disufenton sodium (NXY 059)IBA 10/2004
1	Chlormethiazole (Clomethiazole)IBA 01/2002
1	Excitatory Amino Acid AntagonistsIBA 09/2001
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2001
1	Glycoproteins (Glycoprotein)IBA 04/2001
1	Platelet Membrane GlycoproteinsIBA 04/2001
1	Therapeutic UsesIBA 04/2001
1	Protein Kinase InhibitorsIBA 03/2001
1	fasudil (AT 877)IBA 03/2001
1	Liposomes (Liposome)IBA 03/2001
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2000
1	gamma-Aminobutyric Acid (GABA)IBA 08/2000
1	Clopidogrel (Plavix)FDA Link 06/2000
1	Adenosine Diphosphate (ADP)IBA 06/2000
1	lotrafibanIBA 06/2000
1	tetrachloroisophthalonitrile (Bravo)IBA 06/2000
1	thienopyridineIBA 06/2000
1	Ticlopidine (Ticlid)FDA LinkGeneric 06/2000
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 05/2000
1	MagnesiumIBA 05/2000
1	ChloridesIBA 05/2000
1	phenyl-N-tert-butylnitroneIBA 05/2000
1	Oxygen (Dioxygen)IBA 05/2000
1	Free Radical ScavengersIBA 05/2000
1	Ethanol (Ethyl Alcohol)IBA 02/2000
1	Cytidine Diphosphate Choline (Citicoline)IBA 02/2000
1	Glucose (Dextrose)FDA LinkGeneric 01/2000
1	Alanine (L-Alanine)FDA Link 01/2000
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2000
1	Glutamine (L-Glutamine)FDA Link 01/2000
1	Serine (L-Serine)FDA Link 01/2000

Therapy/Procedure

6	Therapeutics 01/2018 - 03/2000
2	Thrombolytic Therapy 07/2014 - 10/2004
2	Catheters 12/2013 - 12/2012
1	Laser Therapy (Surgery, Laser) 10/2014
1	Lasers (Laser) 10/2014
1	Spinal Injections 03/2001
1	Suture Techniques 03/2001